OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

Abroad (travel likely)Recruiting

Conditions

Obesity and Type 2 Diabetes · NAFLD - Non-Alcoholic Fatty Liver Disease · Hypertension · Dyslipidaemia · Telemedicine

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Changi General Hospital, Singapore, Singapore
Contact: Study coordinator (Geraldine Lim) · geraldine.lim.x@singhealth.com.sg · +65 64267818

Study leads

Joan Khoo, MBBS, FRCP
Principal Investigator
Changi General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Gut Microbiota in Metabolic Surgery

Bariatric Surgery Candidate · Cardiovascular Diseases · Type 2 Diabetes

Abroad (travel likely)Recruiting

Nashville, United States

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

Obesity · Non-Alcoholic Fatty Liver Disease · Diabetes Mellitus, Type 2

Abroad (travel likely)Recruiting

Columbia, United States

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Type 2 Diabetes Mellitus (T2DM) · Type 2 Diabetes · Diabetes Mellitus

Abroad (travel likely)Recruiting

Sakai, Japan

Effects of VLCKD in Metabolic Syndrome

Diabetes Mellitus, Type 2 · Non-alcoholic Fatty Liver Disease · Obesity

Abroad (travel likely)Recruiting

Novara, Italy